Candy Tsourounis, Pharm.D., FCSHP Steering Committee Chair
Professor of Clinical Pharmacy
Department of Clinical Pharmacy
Medication Outcomes Center
School of Pharmacy at the University of California San Francisco
San Francisco, California
Candy Tsourounis, Pharm.D., is Professor of Clinical Pharmacy in the Department of Clinical Pharmacy in the School of Pharmacy at the University of California San Francisco (UCSF). She received her Doctor of Pharmacy degree from the University of Illinois at Chicago. Dr. Tsourounis is involved in providing evidence-based reviews of recently approved prescription medications and performing medication utilization analyses in the UCSF Medication Outcomes Center
Dr. Tsourounis has various areas of research interest including Drug Information, Consumer Self-Care and Complementary and Alternative Medicine (CAM). Specifically, Dr. Tsourounis' research focuses on dietary supplements and drug-supplement interactions. Dr. Tsourounis is very involved in educating consumers and health professionals on the rational use of CAM therapies as well as prescription and non-prescription drug products. Dr. Tsourounis co-coordinates an evidence-based course in herbal remedies and dietary supplements. She has co-authored various book chapters on Herbs and Dietary Supplements for health care professionals. Dr. Tsourounis serves as a clinical consultant and editor for various drug information publications and computer software programs particularly in the area of herbal remedies and dietary supplements. She has coordinated various continuing education programs for national pharmacy societies on herbs and dietary supplements and has been asked to speak on this topic at both statewide and national educational programs.
Karl F. Gumpper, MSMI, RPh, BCPS, CPHIMS, FASHPPharmacy Informatics Manager
Boston Children's Hospital
Department of Pharmacy
Karl F. Gumpper, MSMI, RPh, BCPS, CPHIMS, FASHP, is the Pharmacy Informatics Manager at Boston Children's Hospital. He has been in this role for over 3 years. He leads a team of 3 pharmacists and 3 pharmacy technicians, who are responsible for all aspects of pharmacy informatics, technology, and automation for the institution.
Mr. Gumpper received his Bachelor of Science in Pharmacy from Northeastern University and a Masters in Medical Informatics (MSMI) from Northwestern University. He is a Certified Professional in Health Information and Management Systems (CPHIMS) and a Board Certified Pharmacotherapy Specialist (BCPS). He completed a pharmacy practice residency at Children's National Medical Center in Washington, DC. He began his career at the University of Maryland Medical Center in Baltimore, MD as a clinical pharmacist in neonatology and nutrition support. He returned to Children's National Medical Center as a clinical manager and residency program director. He then went on to become the first Director of the Section of Pharmacy Informatics and Technology (SOPIT) at the American Society of Health-System Pharmacists (ASHP).
Mr. Gumpper was an active member of many of the local pharmacy organizations in the DC metropolitan area. He is a former president of the Washington Metropolitan Society of Health-System Pharmacists (WMSHP) and the Maryland Society for Parenteral and Enteral Nutrition (MSPEN). He has presented on various pediatric, nutrition, and technology topics regionally, nationally, and internationally. He participated on the American Informatics Medical Association (AMIA) work group on Advanced Interprofessional Informatics Certification (AIIC). He was recognized as a Fellow of the American Society of Health‐System Pharmacists (FASHP) and also received the ASHP Section of Pharmacy Informatics and Technology's Distinguished Service Award.
Joel A. Hennenfent, Pharm.D., M.B.A., BCPS, FASHPSystem Director of Pharmacy Services
Truman Medical Centers
Kansas City, Missouri
Joel A. Hennenfent, Pharm.D., M.B.A., BCPS, FASHP is System Director of Pharmacy at Truman Medical Centers in Kansas City, Missouri. He earned his Bachelor of Science and Doctor of Pharmacy degrees at St. Louis College of Pharmacy, completed a Pharmacy Practice Residency at Barnes-Jewish Hospital, and a Master’s degree in Business Administration from Saint Louis University.
Joel is a Past President of Missouri Society of Health-System Pharmacists (MSHP), Past President of the St. Louis Society of Health-System Pharmacists, and Past Chair of the MSHP Research & Education Board. Moreover, he was the 2013 American Society of Health-System Pharmacists (ASHP) Council on Therapeutics Chair, 2015-2017 ASHP Section of Clinical Specialists and Scientists Executive Committee Director-at-Large, and a 2014-2018 and 2015-2019 ASHP Foundation Pharmacy Forecast Advisory Committee member.
He received the 2012 MSHP Pharmacist of the Year award, was the 2015 MSHP Foundation Garrison Award Recipient, and is currently serving as an ASHP Delegate for Missouri. Joel has experience in clinical, quality, safety, regulatory, operational, and supply chain program development.
Ali McBride, Pharm.D., M.S., BCPS, BCOP, FASHPClinical Coordinator of Hematology/Oncology
The University of Arizona Cancer Center
Clinical Assistant Professor
The University of Arizona College of Pharmacy
Ali McBride, Pharm.D., M.S., BCPS, BCOP, is the Clinical Coordinator of Hematology/Oncology at The University of Arizona Cancer Center. He currently serves as Secretary of the Association of Community Cancer Centers (ACCC) and he has been actively involved with the American Society of Health-System Pharmacists (ASHP) currently serving as the Chair for the Section Advisory Group on Emerging Sciences in the Section of Clinical Specialists and Scientists.
Dr. McBride has been working on oncology drug shortages and has testified on behalf of Hematology/Oncology Pharmacy Association (HOPA) at the FDA Drug Shortage Workshop, presented on behalf of the Association of Community Cancer Centers (ACCC) at the Washington D.C. Congressional Session and was an invited member of the ASHP Drug Shortage Stakeholders Meeting. Dr. McBride is also actively involved with biosimilar regulation and the pharmacogenomic impact of biosimilars into the United States marketplace. He currently serves as a working group member for HOPA on its biosimilar committee. In addition, he currently serves on the National Quality Forum (NQF) Cancer Standing Committee. He has published numerous articles focusing on drug shortages, oral chemotherapy adherence, stem cell transplant, and biosimilar implementation into the U.S. health care market